Increased iron and free radical generation in preclinical Alzheimer's disease and mild cognitive impairment

Manuscript Number: 

9-622R1

Author(s): 
Mark L. Cohen, Takaaki Hayashi, Gang Liu, Daniel W. McKeel, Jr., Masao Nakamura, Akihiko Nunomura, George Perry, Sandra L. Siedlak, Mark A. Smith, Massimo Tabaton, Xinglong Wang, Xiongwei Zhu

Disclosures

Mark L. Cohen

  • Nothing to Disclose

Takaaki Hayashi

  • Nothing to Disclose

Gang Liu

  • Nothing to Disclose

Daniel W. McKeel, Jr.

  • Nothing to Disclose

Masao Nakamura

  • Nothing to Disclose

Akihiko Nunomura

  • Nothing to Disclose

George Perry

  • Consulting Fees:
    Neurotez
    Equity:
    Neurotez Voyager Panacea

Sandra L. Siedlak

  • Nothing to Disclose

Mark A. Smith

  • Consulting Fees:
    Advana Science; Anavex Life Sciences Corporation; Lytmos Group, Inc.; Medivation, Inc.; Neurotez; Olson Research Group
    Equity:
    Neurotez, Panacea Pharmaceuticals, Voyager
    Lecture Fees:
    Medivation/Pfizer

Massimo Tabaton

  • Nothing to Disclose

Xinglong Wang

  • Nothing to Disclose

Xiongwei Zhu

  • Nothing to Disclose